Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Iodine | HCID 807 | — |
| Reactant | Triphenylphosphine | HCID 11776 | — |
| Reactant | 14675-48-0 | HCID 97131 | — |
| Reactant | 1H-Purine, 6-methyl- | HCID 5287547 | — |
| Solvent | HCID 22143352 | HCID 22143352 | — |
| Product | HCID 67259647 | HCID 67259647 | — |
Reaction Steps
The reaction is carried out according to Example 5 starting from 6-Methyl-9-(β-D-ribofuranosyl)purine (2a in Table VII) (108 mg, 0.41 mmol), triphenylphosphine (361 mg, 1.36 mmol), and imidazole (185 mg, 2.70 mmol) in M-PYROL (2 ml). Hassan et al., Convenient Synthesis of 6-Methylpurine and Related Nucleosides, Nucleosides, Nucleotides, & Nucleic Acids, 19, 1123-1134 (2000). Iodine beads (1-3 mm) (339 mg, 1.33 mmol) are added over 10 min. The resulting red solution is stirred at room temperature for 4 h at which time TLC indicated complete reaction. No further addition of reagents is required. After aqueous workup and purification by preparative TLC as described for per Example 5, pure 2b (93 mg, 61%) crystallized from 1:1 H2O/MeCN as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07488598B2 |
|---|
| Source dataset | uspto-grants-2009_02 |
|---|
| ORD ID | ord-9ea23a56a2514b62a7899dccf9cdbca8 |
|---|
| Source note | uspto-grants-2009_02 |
|---|